Position in VTRS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,037,832
+$306,580 QoQ
Shares Held
128,327
+0.1% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#252
of 1,016 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026XPONANCE LLC holds $26,283,345 across 23 Drug Manufacturers - Specialty & Generic names. VTRS ranks #4 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
109,299 | $7,854,226 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
27,419 | $4,621,198 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
7,508 | $4,068,059 | |
| 4 | VTRS |
Viatris Inc
This page
|
128,327 | $2,037,832 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
59,638 | $1,467,691 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
31,419 | $1,089,296 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
9,599 | $1,064,913 | |
| 8 | ALKS |
Alkermes plc.
|
16,250 | $851,500 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,037,832 | 128,327 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,731,252 | 128,146 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,242,883 | 99,830 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $903,978 | 91,311 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,151,916 | 128,994 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,638,586 | 188,127 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $2,279,495 | 183,092 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,883,304 | 162,214 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,686,651 | 158,669 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,931,127 | 161,736 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,661,322 | 153,400 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $1,631,021 | 165,418 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $1,642,029 | 164,532 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $1,572,225 | 163,433 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $1,740,809 | 156,407 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $1,138,655 | 133,645 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $1,169,205 | 111,672 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $851,229 | 78,238 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $1,033,056 | 76,353 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $841,685 | 62,117 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $966,618 | 67,643 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $727,976 | 52,110 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,003,058 | 53,525 | Shares | Sole | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||